RUNX3 and cancer: Moreover, all the gene methylation events examined in multiple studies and significant associated with GC (including p16, DAPK, CHFR, MLH1, RUNX3) have been implicated as risk markers of many other cancer types [26], [27], [50], raising questions about the interpretation of their detection in asymptomatic individuals.